[Anticancer activity of oxovanadium compounds]
| Autor: | O. Yu. Abakumova, N. F. Belayeva, O. V. Podobed, A. I. Tochilkin |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
Clinical Biochemistry
Vanadium chemistry.chemical_element Human skin Antineoplastic Agents Biochemistry PC12 Cells General Biochemistry Genetics and Molecular Biology Mice Neoplasms Cytotoxic T cell Animals Humans Cytotoxicity Dose-Response Relationship Drug Chemistry Cytotoxins HEK 293 cells General Medicine Hep G2 Cells Molecular biology Rats Dose–response relationship HEK293 Cells Cell culture Cancer cell NIH 3T3 Cells Molecular Medicine Drug Screening Assays Antitumor Vanadates |
| Zdroj: | Biomeditsinskaia khimiia. 59(3) |
| ISSN: | 2310-6972 |
| Popis: | Cytotoxic and antitumor activity of the biligand vanadyl derivative of L-malic acid (bis(L-malato)oxovanadium(IV) (VO(mal) ) was investigated in comparison with inorganic vanadium(IV) compound - vanadyl sulfate (VOSO ) and also with oxovanadium monocomplex with L-malic acid (VO(mal)) and vanadyl biscomplex with acetylacetonate. In this purpose the effect of vanadyl compounds on growth of normal human skin fibroblasts and tumor cells of different lines: mouse fibrosarcoma (L929), rat pheochromocytome (PC12), human liver carcinoma (HepG2), virus transformated mouse fibroblast (NIN 3T3), virus transformated cells of human kidney (293) were investigated. The results showed that VO(mal) was not toxic for normal human skin fibroblasts but considerably inhibited growth of cancer cells in culture. Cytotoxic antitumor effect of vanadium complexes was found to be dependent оn incubation time and concentration and on type of cells and nature of ligands of the central group of the complex (VO2+). These studies provide evidence that VO(mal) may be considered as a potential antitumor agent due to its low toxicity in non-tumor cells and significant anticancer activity. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|